EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,659 | -82.7% | 394 | -74.8% | 0.00% | -100.0% |
| Q1 2023 | $44,286 | +188.6% | 1,561 | +197.3% | 0.00% | – |
| Q4 2022 | $15,346 | +27.9% | 525 | +12.7% | 0.00% | – |
| Q3 2022 | $12,000 | -61.3% | 466 | -32.6% | 0.00% | -100.0% |
| Q2 2022 | $31,000 | +342.9% | 691 | +370.1% | 0.00% | – |
| Q1 2022 | $7,000 | +75.0% | 147 | +67.0% | 0.00% | – |
| Q4 2021 | $4,000 | -42.9% | 88 | -28.5% | 0.00% | – |
| Q3 2021 | $7,000 | +40.0% | 123 | +10.8% | 0.00% | – |
| Q2 2021 | $5,000 | +25.0% | 111 | +20.7% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 92 | -3.2% | 0.00% | – |
| Q4 2020 | $4,000 | 0.0% | 95 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | +300.0% | 95 | +352.4% | 0.00% | – |
| Q2 2020 | $1,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |